Translational Immunology and Nanotechnology

Combining technology and immunology for direct translation in human medicine and general health.

The TIN Theme (TINT) began in 2019, led by Dist. Prof. Magdalena Plebanski, as a world-class translational research program, driving innovation in omics/precision medicine, nanotechnology and point-of-care devices. 
 
TINT focuses on conditions with dysregulated immunity and inflammation, across four research groups: 

  1. Cancer, Ageing and Vaccines (CAVA) - Nanoparticles, Ovarian Cancer, Vaccines, Ageing, Clinical Trials
  2.  Nanotechnology and Biopharmaceutics (NanoBioPharm) - Drug Delivery Systems, Drug discovery, Biological Medicines, Nanostructures, Biophysics, Pre-clinical Research
  3.  Mechanobiology and Microfluidics - Heart Disease, Ageing
  4. Nutrition, Metabolism and Immunity – Diabetes, Obesity, Clinical Trials

TINT’s individual research groups each have a history of success in obtaining competitive local and international funding (e.g. ARC, NHMRC, NIH, JDRF), and collaboration with industry. They have an outstanding publication record including such journals as: The Lancet, Nature, Science, Nature Biotechnology, Immunity, Circulation and Nature Medicine amongst many others. TINT labs have also successfully supervised many PhDs, who went on to great careers in academia or industry. PhD scholarships are currently available. TINT welcomes Honours and Masters student enquiries.

Common interests that bring TIN Labs together include

Nanotechnology innovations for diabetes, infectious diseases and cancer

Ageing and the immune system

Omics, Artificial Intelligence and Bioinformatics in Human Clinical Trials

Key research areas

TINT comprises of four research groups, each led by researchers at the top of their fields.

Cancer, Ageing & Vaccines Research Group

Head: Distinguished Professor Magdalena Plebanski | Director: Biomedical & Health Innovation Enabling Capability Platform

Mechanobiology & Microfluidics Research Group

Head: Dr Sara Baratchi | Senior Lecturer & Course Coordinator (MEDS2138)

Nanotechnology & Biopharmaceutics (NanoBioPharm) Research Group

Head: Dr Céline Valéry | Senior Lecturer (Pharmaceutical Sciences)

Nutrition, Metabolism & Immunity Research Group

Head: Professor Catherine Itsiopoulos | Dean, School of Health and Biomedical Sciences

Get in touch

To learn more about the TINT, or if you would like to discuss potential membership or collaborations, please contact TINT@rmit.edu.au

aboriginal flag
torres strait flag

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Luwaytini' by Mark Cleaver, Palawa.

aboriginal flag
torres strait flag

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business.